Nostopharma, LLC

Nostopharma, LLC is a women-owned pharmaceutical company specializing in treatments for bone and connective tissue disorders via precision drug delivery. The company is developing sustained-release, biodegradable nanoparticle delivery systems for soft tissue trauma complications. In 2023, TEDCO invested $250,000 in Nostopharma to advance its orthopedic patient care therapeutics.